Menopausal Hormone Therapy: Let the Women Decide
Dr Andrew Kaunitz recommends keeping our eyes on the ‘big picture’ in decisions about the use of menopausal hormone therapy. Medscape Ob/Gyn …read more
Dr Andrew Kaunitz recommends keeping our eyes on the ‘big picture’ in decisions about the use of menopausal hormone therapy. Medscape Ob/Gyn …read more
Post-hoc analysis of the FRAME study indicates that romosozumab is effective for osteoporosis, and safe, across most stages of renal disease. Medscape Medical News …read more
A European Medicines Agency committee warns against using certain estradiol creams for longer than a single period of 4 weeks to reduce the risk for adverse health effects. International Approvals …read more
Trifarotene cream 0.005% (Aklief), approved for patients aged 9 years or older, is the first topical treatment specifically studied and proven to treat acne vulgaris on both the face and trunk. FDA Approvals …read more
Natural treatments and lifestyle changes, such as diet changes, supplements, and herbal remedies, may help with the symptoms of polycystic ovary syndrome (PCOS). Learn what the research says here. …read more
Reducing obese mothers’ sedentary time lowered fat mass and leptin levels in their newborns, indicating more attention should be given to getting these women to limit their sitting time. Medscape Medical News …read more
Breastfeeding, eating a healthful diet, and gentle exercise can all aid postpartum weight loss. Learn how to lose weight safely after pregnancy here. …read more
An intrauterine device (IUD) is a form of physical contraceptive. The two types of IUD are hormonal and copper. Discover how each one can affect a woman’s period here. …read more
The recent surge of lung injuries among users of e-cigarette products appears to be caused by chemical toxicity and not from the accumulation of lipids in the lungs, researchers say. Medscape Medical News …read more
Early trial results suggest the investigational humanized anti-IgE monoclonal antibody ligelizumab binds to IgE with greater affinity than FDA-approved omalizumab for refractory chronic spontaneous urticaria. Medscape Medical News …read more